Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

Daphne Berryhill is an oncology pharmacist and freelance writer. She loves the collaborative process of creating health content. Her goal as a writer is to offer information that’s meaningful, ...

Saxenda (liraglutide) and Wegovy (semaglutide) are prescription drugs used for weight loss and weight management. Both drugs come as a liquid solution injected under your skin. Saxenda is available in ...

Saxenda (liraglutide) and Wegovy (semaglutide) are brand-name injections. They’re both prescribed for weight loss and long-term weight management. Saxenda is used daily, while Wegovy is used weekly.

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

Ozempic and its weight-loss cousin, Wegovy, outperform an earlier drug targeting the same gut hormone, a new study shows Ozempic produced 10% or more weight loss in 61% of obese people compared with ...

Saxenda is a brand-name subcutaneous injection that doctors often prescribe to help some people lose weight. You should keep opened Saxenda pens in the refrigerator but dispose of them after 30 days.

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

While Novo Nordisk A/S NVO is still struggling with a shortage of its popular obesity medicine Wegovy (semaglutide), another weight loss drug has also made it to the FDA's list of drugs facing a ...